Gates Package — page 38

Casco, Tony (NIH/NIAID) [C] From: Hayden, Frederick G *HS <jjj@hscmail.mcc.virginia.edu> Sent: Wednesday, August 06, 2014 12:02 PM To: Olinger, Gene (NIH/NIAID) [C]; Hensley, Lisa (NIH/NIAID) [E]; Jahrling, Peter (NIH/NIAID) [E]; Kobinger, Gary (Public Health Agency of Canada) Cc: Pierre Formenty; @ who. int; Shindo, Nikki; JO who .int; JO who int; HO who.int Subject: RE: Ebola WG Teleconference Thursday 10 am EDT; 15:00 BST Importance: High It would be very helpful to know in advance of tomorrow's teleconference about the timelines or actual results of the repeat testing of favipiravir (T-705) in the EBOV rhesus model. This drug is approved for very restricted influenza indications in Japan and has been offered to WHO for potential use in EVD. Thanks for any insights, fgh From: Gail Carson (RO 1 dm. ox.ac.uk] Sent: 06 August 2014 11:17 To: Hayden, Frederick G *HS; EEO who. int; JO linkp.com; JO who.int Cc: Trina Racine; JNO who.int; Gary (Public Health Agency of Canada) Kobinger; EEN nih.gov (C] Olinger; Peter (NIH/NIAID) [E] Jahrling; who. int; Larry Zeitlin; Lisa (NIH/NIAID) [E] Hensley; Miles Brennan; who. int; deborah scott; Bg aa Tara Nyhuis; © WELLCOME.AC.UK; med.navy.mil; Mike Hensley; Marshall Hoke; [EO mac.com; Brooks, Abdullah; imperial.ac.uk; Kajsa-Stina Longuere; Gail Carson Subject: RE: Ebola WG Teleconference Thursday 10 am EDT; 15:00 BST Dear All, We are looking forward to speaking with you tomorrow Thursday August 7th at 11am EDT. I have attached the minutes of the last call (thank you Gene) and an article that Tom/Fred wished to share. A few new people will join us tomorrow & I am sure they will introduce themselves then. The agenda is below. Professor Hayden will chair. I have also attached the dial in numbers. The participant PIN is NY 1.Welcome- FH 2.Roll-call and introduction of new participants- FH 3.WHO Perspectives- David Wood, Martin Friede 4.Update on siRNAlan MacLachlan (Tekmira) 5.Update on rVSV-GP vaccine- Jay Ramsey (Bioprotection Systems) 6.Screening of FDAapproved Drugs- Gene Olinger (NIH) 7.Development of draft HCW protocols- Mike Hensley AOB 8. Discussion and future actions- All Best wishes Gail Dr Gail Carson Clinical Coordinator ISARIC Consultant in Infectious Diseases Centre for Tropical Medicine and Global Health Oxford University, UK Honorary Consultant Public Health England https://isaric.tghn.org/